{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1200, 
        1209
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1226, 
        1249
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1279, 
        1299
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1109, 
        1136
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        720, 
        749
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1043, 
        1069
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1178, 
        1199
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1091, 
        1106
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160503165612|3E18C547BF5DED0B84DE9E9D925F997EA5ACD161|ORU^R01|99999999999999999999|P|2.5|\nPID|1||99999999^^^^CMR^HOSPITAL 9&9999&MOH~99999999^^^^^HOSPITAL 9&9999&MOH~99999999^^^^MRN^HOSPITAL 9&9999~9999999999&XC&ON^^^^JHN||XXXXXXXX^XXXXXX XXXXXX||99999999|M||E|99 XXXXX XX^^XXXXXXXXXXX^XX^X9X9X9^999||9999999999^XC^OHIN|(613)858-8833X0000||M||6299131042^XC^OHIN||||||||||||N|\nOBR|1||SP1616467|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160422083800|||67524^XXXXXX^XXXXXXXXXXX^^^^XX||||20160422124348|bladder lesions and prostate tissue|999999^XXXXXX^XXXXXXXXXXX^^^^XX||||N|20082009|20160503165612|||F|||||||99999^XXXXXXXXXX^XXXXXX^^^^XX, XXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1. The specimen is received in a container labelled with the patient's name who has the initial \" CI\" and the specimen site \"bladder lesions and prostate tissue\".\nMultiple curetted fragments of tissue.\nWeight: 0.6 g\nCalculi: No\nOther: nil.\n1A-in total\nSSA   2016-04-26   TOH General Campus\n\n\nPath report.site of origin\n\nbladder lesions and prostate tissue\n\n\nPath report.final diagnosis\n\n1. Bladder lesions and prostate tissue:\nPoorly differentiated carcinoma (see comment)\n\n\nPath report.relevant Hx\n\nDg: prostate CA hematuria\n\n\nPath report.comments\n\n1. Sections show poorly differentiated carcinoma composed of in sheets of cells with a whispy amphophilic cytoplasm and with atypical nuclei with prominent nucleoli. By immunohistochemistry (performed on block 1A), the tumor cells stain for AR and focally for PSA and CK20. CK 7 and GATA are negative. The overall histological and immunohistochemical features of the tumor are most in keeping with prostatic origin. Gleason grading is not applicable given the history of prior radiation and hormone therapy.\nThe case was reviewed in consultation with Dr. Flood, who concurs with the above interpretation.\n\n\n"
}